C1QTNF6 and diabetic kidney disease: In addition, a previous study found that CTRP6 knockdown could suppress the inflammation, oxidative stress and extracellular matrix accumulation in high glucose-induced glomerular mesangial cells, which provides a basis for CTRP6 to be applied in the treatment of diabetic nephropathy [36].